A股異動 | 東嶽硅材(300821.SZ)續升超7% 第三季淨利同比大增1287%
格隆匯10月21日丨昨日漲7.2%的東嶽硅材(300821.SZ)續升超7%,報26.79元,總市值320億元。公司20日晚公吿,第三季度實現營業收入12.14億元,同比增長97.05%;歸母淨利潤4.08億元,同比增長1286.7%;歸母扣非淨利潤4.07億元,同比增長1161.31%。平安證券維持公司“推薦”評級,預計明年上半年之前有機硅行業仍將保持較高的景氣程度。另外,到2021年底,公司聚硅氧烷產能規模有望進入全球前五位。新增產能預計將助力公司業績增長5億元以上。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.